These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6103572)

  • 1. [Long term drug treatments of schizophrenia].
    des Lauriers A; Allilaire JF
    Rev Prat; 1980 Jan; 30(1):39-46. PubMed ID: 6103572
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of schizophrenia].
    Houy-Durand E; Thibaut F
    Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P
    Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
    [No Abstract]   [Full Text] [Related]  

  • 5. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term medication in schizophrenic psychoses].
    Gaebel W
    Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S26-31. PubMed ID: 10907610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When should drug treatment be initiated in schizophrenia?
    Malla AK
    J Psychiatry Neurosci; 1999 Sep; 24(4):363. PubMed ID: 11499428
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic strategies in the treatment of schizophrenia.
    Rifkin A
    Psychiatr Clin North Am; 1993 Jun; 16(2):351-63. PubMed ID: 8101372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacogenetics of antipsychotics in schizophrenia].
    Méary A
    Therapie; 2008; 63(3):243-6. PubMed ID: 18718213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
    Altamura AC; Bobo WV; Meltzer HY
    Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
    Müller P
    Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintenance therapy in schizophrenia.
    Marder SR
    Curr Psychiatr Ther; 1983; 22():141-50. PubMed ID: 6145546
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term phase of schizophrenia: impact of atypical agents.
    Naber D
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S11-4. PubMed ID: 11252518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In conclusion: does antipsychotic treatment modify the long-term course of schizophrenic illness?
    Tandon R
    J Psychiatr Res; 1998; 32(3-4):251-3. PubMed ID: 9793878
    [No Abstract]   [Full Text] [Related]  

  • 19. [Longterm therapy of schizophrenia].
    Pajonk FG; Wobrock T; Falkai P
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antipsychotic agents are best chosen by their adverse effect profile].
    Msghina M; Lindefors N
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2841-2, 2844-6. PubMed ID: 19967963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.